1. The Antidiabetic Armamentarium: Reducing the Residual Cardiovascular Risk with HbA_1c(v)-Lowering Medications

   • Matthew D. Stryker
   • Joshua Schulman-Marcus
   • Mandeep S. Sidhu

   EDITORIAL 17 February 2018 Pages: 1 - 3

2. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway

   • Kuixiang Chen
   • Mubarak Rekep
   • Yinghua Liu

   ORIGINAL ARTICLE 12 February 2018 Pages: 5 - 21

   

3. Unsafe Drug Use and Arrhythmic Events in Brugada Patients with ICD: Results of a Long-Term Follow-Up

   • Diogo de Almeida Fernandes
   • Natália António
   • Guilherme Mariano Pego

   ORIGINAL ARTICLE 25 January 2018 Pages: 23 - 28

   

4. Unmet Patient Need in Statin Intolerance: the Clinical Characteristics and Management

   • Teresa N. Harrison
   • Jin-Wen Y. Hsu
   • Kristi Reynolds

   ORIGINAL ARTICLE 07 February 2018 Pages: 29 - 36

   

5. Mind the Gap: Mismatches Between Clinicians and Patients in Heart Failure Medication Management

   • Ken Lee Chin
   • Marina Skiba
   • Danny Liew

   ORIGINAL ARTICLE 09 January 2018 Pages: 37 - 46

   

6. Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study

   • Runlin Gao
   • Yongjian Wu
   • on behalf of the DAYU study investigators

   ORIGINAL ARTICLE Open access 28 February 2018 Pages: 47 - 56

   

7. Does Statin Benefits Patients with Heart Failure Undergoing Percutaneous Coronary Intervention? Findings from the Melbourne Interventional Group Registry

   • Ken Lee Chin
   • Rory Wolfe
   • for the Melbourne Interventional Group (MIG)

   ORIGINAL ARTICLE 18 January 2018 Pages: 57 - 64

   

8. GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials

   • Xiaoming Jia
   • Mahboob Alam
   • Yochai Birnbaum

   ORIGINAL ARTICLE 14 February 2018 Pages: 65 - 72

   

9. Effect of Anagliptin and Sitagliptin on Low-Density Lipoprotein Cholesterol in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: Rationale and Study Design of the REASON Trial

   • Shinichiro Ueda
   • Michio Shimabukuro
   • Takeshi Morimoto

   ORIGINAL ARTICLE Open access 12 February 2018 Pages: 73 - 80

   

10. The Incidence and the Prognostic Impact of Acute Kidney Injury in Acute Myocardial Infarction Patients: Current Preventive Strategies

    • Evangelos Kaltsas
    • George Chalikias
    • Dimitrios Tziakas

    REVIEW ARTICLE 19 January 2018 Pages: 81 - 98

    

11. New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors

    • Juan Tamargo
    • Ricardo Caballero
    • Eva Delpón

    REVIEW ARTICLE 25 January 2018 Pages: 99 - 119

    

12. Clinical Review of the Pharmacogenomics of Direct Oral Anticoagulants

    • Andrew S. Tseng
    • Reema D. Patel
    • Fadi E. Shamoun

    REVIEW ARTICLE 13 February 2018 Pages: 121 - 126